Healthcare Realty Trust (NYSE:HR) Updates FY 2025 Earnings Guidance

Healthcare Realty Trust (NYSE:HR) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 1.560-1.600 for the period, compared to the consensus earnings per share estimate of 1.590. The company issued revenue guidance of -. Healthcare Realty Trust also updated its FY25 guidance to $1.56 to $1.60 EPS.

Healthcare Realty Trust Trading Down 0.4 %

Shares of HR stock opened at $16.71 on Thursday. The firm has a market capitalization of $5.92 billion, a PE ratio of -10.56 and a beta of 0.94. The firm has a fifty day simple moving average of $16.68 and a two-hundred day simple moving average of $17.42. Healthcare Realty Trust has a 12 month low of $12.77 and a 12 month high of $18.90.

Healthcare Realty Trust (NYSE:HR) last announced its quarterly earnings results on Wednesday, February 19th. The real estate investment trust reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.39 by $0.01. The business had revenue of $309.77 million during the quarter, compared to analyst estimates of $303.81 million. Healthcare Realty Trust had a negative net margin of 45.63% and a negative return on equity of 9.42%. Healthcare Realty Trust’s quarterly revenue was down 6.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.39 EPS. On average, equities analysts predict that Healthcare Realty Trust will post 1.55 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the stock. Wedbush lowered shares of Healthcare Realty Trust from a “neutral” rating to an “underperform” rating and reduced their target price for the stock from $18.00 to $16.00 in a research note on Thursday, January 2nd. Jefferies Financial Group downgraded shares of Healthcare Realty Trust from a “buy” rating to a “hold” rating and cut their price target for the stock from $19.00 to $17.00 in a report on Thursday, January 2nd. Finally, JPMorgan Chase & Co. downgraded shares of Healthcare Realty Trust from an “overweight” rating to a “neutral” rating and set a $19.00 price target on the stock. in a report on Friday, December 20th. Two analysts have rated the stock with a sell rating and four have issued a hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $17.00.

Insider Buying and Selling at Healthcare Realty Trust

In related news, Director Peter F. Sr Lyle, Sr. purchased 10,000 shares of the firm’s stock in a transaction dated Friday, December 13th. The shares were purchased at an average cost of $17.21 per share, for a total transaction of $172,100.00. Following the completion of the transaction, the director now directly owns 26,576 shares in the company, valued at approximately $457,372.96. This represents a 60.33 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Thomas N. Bohjalian purchased 7,750 shares of the firm’s stock in a transaction dated Friday, November 22nd. The shares were bought at an average price of $17.39 per share, for a total transaction of $134,772.50. Following the completion of the transaction, the director now owns 50,002 shares of the company’s stock, valued at approximately $869,534.78. This trade represents a 18.34 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 18,750 shares of company stock valued at $323,723 over the last three months. 0.56% of the stock is currently owned by insiders.

About Healthcare Realty Trust

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.